Myocardial uptake of iodine-125-labeled 15-(P-Iodophenyl)-3-(R,S)- methyl pentadecanoic acid is decreased in chronic diabetic rats with changes in subcellular distribution

Ken Shinmura, Masato Tani, Yukako Suganuma, Hiroshi Hasegawa, Yoko Hayashi, Xing Dong Guo, Yoshiro Nakamura

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Iodine-123-labeled 15-(p-iodophenyl)-3-(R,S)-methyl pentadecanoic acid (123I-BMIPP) is widely used to detect myocardial metabolic changes, but the preferred energy substrates in the myocardium would be expected to be altered in the presence of metabolic disorders such as diabetes mellitus (DM). We investigated the metabolism of branched-chain fatty acids in the myocardium of rats with DM. Streptozotocin-induced DM rats were examined 48 h (acute; AD) and 6 weeks (chronic; CD) after injection of streptozotocin. Hearts were excised 15 min or 60 min after injection of 0.185 MBq of 125I- BMIPP, followed by homogenization in an EDTA-Tris buffer. The homogenates were subjected to differential centrifugation to obtain the mitochondrial (MF) and cytoplasmic (CF) fractions. Myocardial 125I uptake tended to increase in the AD group, but the change was not significant. Myocardial 125I uptake at 15 rain was significantly lower in the CD group than in the control group, even in the insulin-treated rats [control (CC), 4.4±0.4; not treated (CDN), 3.3±0.5; insulin-treated (CDI), 3.4±0.4x104 cpm/g, p<0.05 in each case]. The 125I count value corrected for the blood count (counts/min (cpm) per g of protein divided by blood cpm) in the MF decreased by 40% at 60 min in the CC group, but increased by 60% in the CDN group. The results of the present study suggest that the myocardial uptake of branched- chain fatty acids is decreased in rats with chronic diabetes, probably as a result of mitochondrial dysfunction.

Original languageEnglish
Pages (from-to)364-370
Number of pages7
JournalJapanese Circulation Journal
Volume62
Issue number5
DOIs
Publication statusPublished - 1998 May

Fingerprint

Iodine
Diabetes Mellitus
Myocardium
Fatty Acids
Insulin
Tromethamine
Injections
Experimental Diabetes Mellitus
Rain
Streptozocin
Centrifugation
Edetic Acid
Blood Proteins
Control Groups
pentadecanoic acid
iodofiltic acid

Keywords

  • Diabetes mellitus
  • Fatty acid metabolism
  • Iodine-125-1abeled 15-(p-iodophenyl)-3-(R,S)-methyl pentadecanoic acid (I-BMIPP)
  • Mitochondria
  • Myocardium

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology

Cite this

Myocardial uptake of iodine-125-labeled 15-(P-Iodophenyl)-3-(R,S)- methyl pentadecanoic acid is decreased in chronic diabetic rats with changes in subcellular distribution. / Shinmura, Ken; Tani, Masato; Suganuma, Yukako; Hasegawa, Hiroshi; Hayashi, Yoko; Guo, Xing Dong; Nakamura, Yoshiro.

In: Japanese Circulation Journal, Vol. 62, No. 5, 05.1998, p. 364-370.

Research output: Contribution to journalArticle

Shinmura, Ken ; Tani, Masato ; Suganuma, Yukako ; Hasegawa, Hiroshi ; Hayashi, Yoko ; Guo, Xing Dong ; Nakamura, Yoshiro. / Myocardial uptake of iodine-125-labeled 15-(P-Iodophenyl)-3-(R,S)- methyl pentadecanoic acid is decreased in chronic diabetic rats with changes in subcellular distribution. In: Japanese Circulation Journal. 1998 ; Vol. 62, No. 5. pp. 364-370.
@article{7f38e2d47f854905810d58d53a20538f,
title = "Myocardial uptake of iodine-125-labeled 15-(P-Iodophenyl)-3-(R,S)- methyl pentadecanoic acid is decreased in chronic diabetic rats with changes in subcellular distribution",
abstract = "Iodine-123-labeled 15-(p-iodophenyl)-3-(R,S)-methyl pentadecanoic acid (123I-BMIPP) is widely used to detect myocardial metabolic changes, but the preferred energy substrates in the myocardium would be expected to be altered in the presence of metabolic disorders such as diabetes mellitus (DM). We investigated the metabolism of branched-chain fatty acids in the myocardium of rats with DM. Streptozotocin-induced DM rats were examined 48 h (acute; AD) and 6 weeks (chronic; CD) after injection of streptozotocin. Hearts were excised 15 min or 60 min after injection of 0.185 MBq of 125I- BMIPP, followed by homogenization in an EDTA-Tris buffer. The homogenates were subjected to differential centrifugation to obtain the mitochondrial (MF) and cytoplasmic (CF) fractions. Myocardial 125I uptake tended to increase in the AD group, but the change was not significant. Myocardial 125I uptake at 15 rain was significantly lower in the CD group than in the control group, even in the insulin-treated rats [control (CC), 4.4±0.4; not treated (CDN), 3.3±0.5; insulin-treated (CDI), 3.4±0.4x104 cpm/g, p<0.05 in each case]. The 125I count value corrected for the blood count (counts/min (cpm) per g of protein divided by blood cpm) in the MF decreased by 40{\%} at 60 min in the CC group, but increased by 60{\%} in the CDN group. The results of the present study suggest that the myocardial uptake of branched- chain fatty acids is decreased in rats with chronic diabetes, probably as a result of mitochondrial dysfunction.",
keywords = "Diabetes mellitus, Fatty acid metabolism, Iodine-125-1abeled 15-(p-iodophenyl)-3-(R,S)-methyl pentadecanoic acid (I-BMIPP), Mitochondria, Myocardium",
author = "Ken Shinmura and Masato Tani and Yukako Suganuma and Hiroshi Hasegawa and Yoko Hayashi and Guo, {Xing Dong} and Yoshiro Nakamura",
year = "1998",
month = "5",
doi = "10.1253/jcj.62.364",
language = "English",
volume = "62",
pages = "364--370",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "5",

}

TY - JOUR

T1 - Myocardial uptake of iodine-125-labeled 15-(P-Iodophenyl)-3-(R,S)- methyl pentadecanoic acid is decreased in chronic diabetic rats with changes in subcellular distribution

AU - Shinmura, Ken

AU - Tani, Masato

AU - Suganuma, Yukako

AU - Hasegawa, Hiroshi

AU - Hayashi, Yoko

AU - Guo, Xing Dong

AU - Nakamura, Yoshiro

PY - 1998/5

Y1 - 1998/5

N2 - Iodine-123-labeled 15-(p-iodophenyl)-3-(R,S)-methyl pentadecanoic acid (123I-BMIPP) is widely used to detect myocardial metabolic changes, but the preferred energy substrates in the myocardium would be expected to be altered in the presence of metabolic disorders such as diabetes mellitus (DM). We investigated the metabolism of branched-chain fatty acids in the myocardium of rats with DM. Streptozotocin-induced DM rats were examined 48 h (acute; AD) and 6 weeks (chronic; CD) after injection of streptozotocin. Hearts were excised 15 min or 60 min after injection of 0.185 MBq of 125I- BMIPP, followed by homogenization in an EDTA-Tris buffer. The homogenates were subjected to differential centrifugation to obtain the mitochondrial (MF) and cytoplasmic (CF) fractions. Myocardial 125I uptake tended to increase in the AD group, but the change was not significant. Myocardial 125I uptake at 15 rain was significantly lower in the CD group than in the control group, even in the insulin-treated rats [control (CC), 4.4±0.4; not treated (CDN), 3.3±0.5; insulin-treated (CDI), 3.4±0.4x104 cpm/g, p<0.05 in each case]. The 125I count value corrected for the blood count (counts/min (cpm) per g of protein divided by blood cpm) in the MF decreased by 40% at 60 min in the CC group, but increased by 60% in the CDN group. The results of the present study suggest that the myocardial uptake of branched- chain fatty acids is decreased in rats with chronic diabetes, probably as a result of mitochondrial dysfunction.

AB - Iodine-123-labeled 15-(p-iodophenyl)-3-(R,S)-methyl pentadecanoic acid (123I-BMIPP) is widely used to detect myocardial metabolic changes, but the preferred energy substrates in the myocardium would be expected to be altered in the presence of metabolic disorders such as diabetes mellitus (DM). We investigated the metabolism of branched-chain fatty acids in the myocardium of rats with DM. Streptozotocin-induced DM rats were examined 48 h (acute; AD) and 6 weeks (chronic; CD) after injection of streptozotocin. Hearts were excised 15 min or 60 min after injection of 0.185 MBq of 125I- BMIPP, followed by homogenization in an EDTA-Tris buffer. The homogenates were subjected to differential centrifugation to obtain the mitochondrial (MF) and cytoplasmic (CF) fractions. Myocardial 125I uptake tended to increase in the AD group, but the change was not significant. Myocardial 125I uptake at 15 rain was significantly lower in the CD group than in the control group, even in the insulin-treated rats [control (CC), 4.4±0.4; not treated (CDN), 3.3±0.5; insulin-treated (CDI), 3.4±0.4x104 cpm/g, p<0.05 in each case]. The 125I count value corrected for the blood count (counts/min (cpm) per g of protein divided by blood cpm) in the MF decreased by 40% at 60 min in the CC group, but increased by 60% in the CDN group. The results of the present study suggest that the myocardial uptake of branched- chain fatty acids is decreased in rats with chronic diabetes, probably as a result of mitochondrial dysfunction.

KW - Diabetes mellitus

KW - Fatty acid metabolism

KW - Iodine-125-1abeled 15-(p-iodophenyl)-3-(R,S)-methyl pentadecanoic acid (I-BMIPP)

KW - Mitochondria

KW - Myocardium

UR - http://www.scopus.com/inward/record.url?scp=0031978911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031978911&partnerID=8YFLogxK

U2 - 10.1253/jcj.62.364

DO - 10.1253/jcj.62.364

M3 - Article

C2 - 9626905

AN - SCOPUS:0031978911

VL - 62

SP - 364

EP - 370

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 5

ER -